ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,3461
1,66%
Bitcoin
69.226,65
-2,17%
Brent Oil
79,395
-0,61%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Syneos Health Inc (SYNH)

  7. Syneos Health Inc (SYNH) Notícias

SYNH

Syneos Health (SYNH)

Syneos Health Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SYNH
DataHoraFonteTítuloCódigoCompanhia
29/04/202410:00PR Newswire (US)Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S.NASDAQ:SYNHSyneos Health Inc
12/04/202410:00PR Newswire (US)Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual MeetingNASDAQ:SYNHSyneos Health Inc
08/04/202410:00PR Newswire (US)Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone)NASDAQ:SYNHSyneos Health Inc
10/10/202307:08Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:SYNHSyneos Health Inc
03/10/202309:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SYNHSyneos Health Inc
28/09/202318:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SYNHSyneos Health Inc
28/09/202313:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SYNHSyneos Health Inc
28/09/202311:24GlobeNewswire Inc.Syneos Health Closes Transaction with Private Investment FirmsNASDAQ:SYNHSyneos Health Inc
26/09/202318:41PR Newswire (US)Civitas Resources Set to Join S&P MidCap 400; Hayward Holdings to Join S&P SmallCap 600NASDAQ:SYNHSyneos Health Inc
26/09/202308:30GlobeNewswire Inc.Syneos Health Names Terttu Haring President, Clinical Sites & PatientsNASDAQ:SYNHSyneos Health Inc
26/09/202306:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Syneos Health, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NASDAQ: SYNH)NASDAQ:SYNHSyneos Health Inc
12/09/202308:30GlobeNewswire Inc.Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health EquityNASDAQ:SYNHSyneos Health Inc
06/09/202308:54GlobeNewswire Inc.Syneos Health, Inc. and Star Parent, Inc. Announce Proposed $1.70 Billion Offering of Senior Secured NotesNASDAQ:SYNHSyneos Health Inc
11/08/202306:45PR Newswire (US)SYNH SHAREHOLDER ALERT: Jakubowitz Law Reminds Syneos Shareholders of a Lead Plaintiff Deadline of September 25, 2023NASDAQ:SYNHSyneos Health Inc
02/08/202309:47GlobeNewswire Inc.Syneos Health Stockholders Approve Agreement with Private Investment ConsortiumNASDAQ:SYNHSyneos Health Inc
26/07/202318:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SYNHSyneos Health Inc
10/07/202308:30GlobeNewswire Inc.Syneos Health Appoints Hillary Bochniak as Chief Human Resources OfficerNASDAQ:SYNHSyneos Health Inc
07/07/202318:03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SYNHSyneos Health Inc
27/06/202318:13Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SYNHSyneos Health Inc
26/06/202308:30GlobeNewswire Inc.Syneos Health and uMotif Partner to Deliver Patient-centric eClinical PlatformNASDAQ:SYNHSyneos Health Inc
16/06/202318:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SYNHSyneos Health Inc
15/06/202307:26Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:SYNHSyneos Health Inc
09/06/202311:15Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NASDAQ:SYNHSyneos Health Inc
25/05/202308:30GlobeNewswire Inc.Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health EquityNASDAQ:SYNHSyneos Health Inc
17/05/202308:30GlobeNewswire Inc.Syneos Health Leaders Recognized by HBANASDAQ:SYNHSyneos Health Inc
16/05/202309:05GlobeNewswire Inc.Syneos Health Leaders Recognized as PM360 2023 ELITE Award RecipientsNASDAQ:SYNHSyneos Health Inc
15/05/202309:57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SYNHSyneos Health Inc
10/05/202316:01PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Syneos Health, Inc.NASDAQ:SYNHSyneos Health Inc
10/05/202308:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SYNHSyneos Health Inc
10/05/202308:07GlobeNewswire Inc.Syneos Health Reports First Quarter 2023 ResultsNASDAQ:SYNHSyneos Health Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SYNH

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
SGPS3
SPRINGS ON
BOV
HBOR3
HELBOR ON
BOV
RPMG3
PET MANGUINH ON
BOV
HAGA3
HAGA ON
BOV
KRSA3
Kora Saude Participacoes... ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
TASA4
FORJA TAURUS PN
BOV
COGN3
COGNA ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
RNEW4
RENOVA PN
BOV
AMER3
Americanas ON
BOV
BRKM5
BRASKEM PNA
BOV
GOLL4
GOL PN
BOV
SEQL3
Sequoia Logistica e Tran... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados